Good morning. The Supreme Court is allowing the Trump administration to cut $783 million in research grants tied to DEI work.

These were among the concerns of a recent regulatory inspection of a key, but historically troubled, manufacturing plant that ...

Whether it’s a cook, a home health aide, or a direct support professional, domestic workers are critical for so many people ...

A woman came into triage with her 6-week-old baby, terrified. She had little support at home and was worried about caring for ...

A major U.S. drug manufacturing plant did not properly investigate cat hair, pests, and other problems, the FDA found in a ...

The shooter, identified by authorities as Patrick Joseph White, appears to have been captured in security camera footage ...

Gilead subsidiary Kite Pharma said that it has acquired Interius BioTherapeutics and its single-shot CAR-T program for $350 million.

The Trump administration can slash $783 million of research funding in its push to cut federal diversity, equity and ...

On September 10, join this virtual event to hear industry-leading insights to improve operational efficiency and regulatory ...

CVS Health will not add Gilead Sciences' new HIV prevention drug to its commercial plans for now, despite the medicine's ...

This week on "The Readout LOUD," we discuss Viking Therapeutics' obesity flop and dish on the growing "pharm to table" movement.

The FDA has agreed to speed up a review of a rare disease drug developed by Stealth BioTherapeutics, a notable step after the ...